Clinical trial
D-cycloserine in the Management of Chemotherapy-Induced Peripheral Neuropathic…
NCT00301080 · Northwestern University, Other · Terminated
Key facts
| NCT number | NCT00301080 |
|---|---|
| Title | D-cycloserine in the Management of Chemotherapy-Induced Peripheral Neuropathic Pain |
| Official title | A Phase III Study of D-Cycloserine in the Management of Paclitaxel-Induced Peripheral Neuropathic Pain in Breast Cancer Patients |
| Lead sponsor | Northwestern University, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Neurotoxicity, Pain, Breast Cancer |
| Intervention type | Drug, Other |
| Interventions | D-cycloserine, Placebo |
| Enrollment | 7 |
| Start date | Feb 1, 2006 |
| Primary completion | Feb 1, 2007 |
| Completion | May 1, 2008 |
| First posted | Mar 10, 2006 |
| Last update posted | Dec 2, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: